RT PCR assays in SLNs of malignant melanoma. The peripheral portions of the sentinel lymph nodes (SLNs) were snap frozen and used for molecular genetic analyses. RT PCR amplification using primer sets specific for gp100, MART 1 and tyrosinase cDNA. GAPDH was used as a housekeeping gene.
1
Immunohistochemical stains of SLNs of malignant melanoma. To confirm micrometastases, we stained all of the sections with antibodies to S100, MART 1, HMB 45 and tyrosinase antibodies. The quantitative expression of gp100, MART 1, and tyrosinase mRNA in SLNs. The quantitative expressions of gp100, MART 1, and tyrosinase mRNA were significantly higher in the metastatic SLNs than in the non metastatic SLNs. (histological analysis); tumor cells confirmed by HE and or at least one marker stained by immunohistochemical study.
(molecular analysis); at least one marker expression of mRNA confirmed by RT PCR. ＊Two of the five patients who were positive only by RT PCR were revealed to have micrometastases by repeated immunohistochemi cal staining. The quantitative expression of gp100, MART 1, and tyrosinase mRNA in S classifications of tumor positive SLNs. In the 15 tumor positive sentinel lymph nodes that were confirmed by HE and IHC, we evaluated the expression levels of gp100, MART 1, and tyrosinase mRNA by determining the distance of tumor cell invasion from the capsules. The expression levels tended to increase according to the S classification, but the differences were not significant. 
The expression of MIC markers in primary lesions of MM and normal skin. Primary lesions with SLN metastasis confirmed by HE and IHC (n 8). Primary lesions without SLN metastasis confirmed by HE and IHC (n 6). Normal skin samples (n 7). Among the six MIC markers including ABCB5, CD133, Nestin, CD271, JARID1B and RANK mRNA, the ABCB5 mRNA was specifically detected in the primary lesions of MM that metastasized to the SLNs, but not in the cases without metastasis or normal skin. The KDM5B mRNA expres sion levels were significantly lower in the primary lesions compared to the normal skin samples (p 0.05). The expression of MIC markers in melanoma SLNs and normal LNs. SLN , a tumor positive SLN confirmed by HE and IHC stains (n 23). SLN , a tumor negative SLN confirmed by HE and IHC stains (n 60). Normal LN, lymph nodes from patients with non melanoma disease (n 18). In the SLNs, the expression levels of ABCB5 mRNA were higher in the metastasis positive LNs than in the metastasis negative and normal LNs (p 0.05). No clear differences were observed in the expression levels of CD133, nestin, KDM5B and NGFR mRNA in each group. 
